Table of Content

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Emphasis on Advanced Surveillance in the Supply Chain
4.2.2 Shifting Trend from Packaging Security to On-dosage Security
4.2.3 Supportive Government Legislation
4.3 Market Restraints
4.3.1 Low awareness about Counterfeit Drugs
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Technology
5.1.1 Infrared and Near Infrared Spectroscopy
5.1.2 Microfluidic
5.1.3 Rapid Chemical Testing
5.1.4 Raman Spectroscopy
5.1.5 RFID Technology
5.1.6 Other Technologies
5.2 By Modality
5.2.1 Benchtop Devices
5.2.2 Handheld Devices
5.3 By Application
5.3.1 Chemical Composition
5.3.2 Packaging and Labeling Detection
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bayer AG
6.1.2 Consumer Physics
6.1.3 GAO Group
6.1.4 Konica Minolta Sensing Americas Inc.
6.1.5 RIGAKU CORPORATION
6.1.6 Spectral Engines Oy
6.1.7 Stratio Inc.
6.1.8 Systech International
6.1.9 Thermo Fisher Scientific Inc.


7 MARKET OPPORTUNITIES AND FUTURE TRENDS